A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
NCT ID: NCT06938815
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2025-02-28
2025-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Combination Treatment Reduces Acne Severity and PIHP
NCT05601960
The Efficacy of Bakuchiol in Treating PIH
NCT06833996
Efficacy of La Roche Posay Routine in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP)
NCT06770127
Clinical Efficacy of the Product in the Management of Facial Post Inflammatory Hyperpigmentation (PIHP) Subjects
NCT06822335
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
NCT05362929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pigment Balancing Peel and Post Peel Regimen
Discoloration Defense Serum: Applied twice daily (morning and night) LHA Cleansing Gel: Used twice daily (AM and PM) to cleanse the skin and target discoloration.
Hydrating B5 Gel: Applied throughout the day to hydrate the skin. Brightening UV Defense Sunscreen: Used throughout the day.
Pigment Balancing Peel
Chemical Peel
Discoloration Defense Serum
Dark spot correcting serum
LHA Cleansing Gel
exfoliating gel facial cleanser
Hydrating B5 Gel
Vitamin B5 serum with hyaluronic acid
Daily Brightening Sunscreen
daily moisturizing sunscreen SPF 30
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pigment Balancing Peel
Chemical Peel
Discoloration Defense Serum
Dark spot correcting serum
LHA Cleansing Gel
exfoliating gel facial cleanser
Hydrating B5 Gel
Vitamin B5 serum with hyaluronic acid
Daily Brightening Sunscreen
daily moisturizing sunscreen SPF 30
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of Post Inflammatory Hyperpigmentation
* Non-Caucasian
* Fitzpatrick skin types IV-VI
* Available and willing to comply with study instructions and attend all study visits.
* Able and willing to provide written and verbal informed consent.
Exclusion Criteria
* Caucasian/ Non-Hispanic
* Subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
* Pregnant, lactating, or is planning to become pregnant during the study.
* Subject is currently enrolled in an investigational drug or device study.
* Subject has received an investigational drug or has been treated with an investigational device within 30 days prior to the initiation of treatment (baseline).
* Study participant has facial hair that could interfere with the study assessments in the opinion of the investigator.
* Study participant is unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function.
* Subject has known hypersensitivity or previous allergic reaction to any of the active or inactive components of the test articles.
* Subject has the need or plans to be exposed to artificial tanning devices or excessive sunlight during the trial.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
L'Oreal
INDUSTRY
Narrows Institute for Biomedical Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jared Jagdeo, MD MS
Role: PRINCIPAL_INVESTIGATOR
SUNY Downstate Health Sciences University Department of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York Harbor VA Brooklyn Campus
Brooklyn, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1792718
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.